The use of BNP-type peptides for the stratification of therapy with erythropoietic stimulating agents

Details for Australian Patent Application No. 2007285733 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Escrig, Cesar; Scherhag, Armin; Moecks, Joachim; Amann Zalan, Ildiko; Herrmann, Zuzana; Dougherty, Frank; Burger, Hans Ulrich

Agent Davies Collison Cave

Pub. Number AU-B-2007285733

PCT Pub. Number WO2008/020043

Priority 11/465,191 17.08.06 US

Filing date 15 August 2007

Wipo publication date 21 February 2008

Acceptance publication date 14 October 2010

International Classifications

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/020043 Priority application(s): WO2008/020043

14 October 2010 Application Accepted

  Published as AU-B-2007285733

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007285734-Method and apparatus for liquefying a hydrocarbon-containing feed stream

2007285714-Ntetrahydropyridothiophene derivatives for the treatment of cancer